Preliminary assessment of drug repurposing against virus-associated primary effusion lymphoma
{{output}}
Drug repurposing uses medicine with a given indication to treat a different disease. Primary effusion lymphoma (PEL), a cancer driven by coinfection with the Kaposi sarcoma-associated herpesvirus and the Epstein-Barr virus, lacks an effective treatment. We opt... ...
